文献速递皮肤肿瘤

无创双基因分子检测对皮肤黑色素瘤的诊断价值及活检决策的影响

Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.
PubMed 文献 · JAMA Dermatol · 2017-01-01

该研究通过基于网络的多人多病例评估,让45名皮肤科医生先仅根据临床和皮肤镜图像、再结合无创粘附贴片活检获得的LINC00518/PRAME基因表达信息,判断是否活检色素性皮损。

要点

  • 无创基因表达检测可提高皮肤科医生活检决策的特异性并维持或提升敏感性。
  • 结合检测信息后,活检敏感性从95.0%升至98.6%,特异性从32.1%升至56.9%。
  • 该检测可能增加早期黑色素瘤的活检数量并减少良性皮损的活检。

核心结论

  • 无创色素性皮损检测(PLA)可显著提高皮肤科医生活检决策的特异性,同时维持或提高敏感性。

研究设计与样本

  • 研究为基于安全网络的多读者多病例研究,纳入45名委员会认证的皮肤科医生,每人评估60个临床和皮肤镜图像。
  • 医生先仅根据图像、再结合LINC00518/PRAME基因表达信息及PLA评分和预测值数据,判断是否活检。

关键数值与推荐

  • 无创粘附贴片活检检测LINC00518和PRAME基因表达,并计算PLA评分。
  • PLA信息包括基因表达结果和预测值数据。
  • 主要结局指标为有无PLA数据时的活检敏感性和特异性。

临床怎么用

  • 皮肤科医生在评估临床非典型色素性皮损时,可结合无创PLA基因表达信息优化活检决策。
  • 该检测有助于提高活检特异性,可能减少良性皮损的活检数量。
  • 该检测可能增加早期黑色素瘤的活检数量,从而改善患者结局并降低医疗费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Expression of long intergenic non-protein coding RNA 518 (LINC00518) and preferentially expressed antigen in melanoma (PRAME) genes, obtained via noninvasive adhesive patch biopsy, is a sensitive and specific method for detection of cutaneous melanoma. However, the utility of this test in biopsy decisions made by dermatologists has not been evaluated. OBJECTIVE: To determine the utility of the pigmented lesion assay (PLA) for LINC00518/PRAME expression in decisions to biopsy a series of pigmented skin lesions. DESIGN, SETTING, AND PARTICIPANTS: In this secure web-based, multiple-reader-multiple-case study, 45 board-certified dermatologists each evaluated 60 clinical and dermoscopic images of clinically atypical pigmented lesions, first without and then with PLA gene expression information and were asked whether the lesions should be biopsied. Data were collected from March 24, 2014, through November 13, 2015. INTERVENTIONS: Participants were given a report for each lesion, which included the results of an assay for expression of LINC00518/PRAME and a PLA score with data on the predictive values of the information provided. MAIN OUTCOMES AND MEASURES: Biopsy sensitivity and specificity with vs without PLA data. RESULTS: Forty-five dermatologists (29 male and 16 female) performed the evaluation. After incorporating the PLA into their decision as to whether to biopsy a pigmented lesion suggestive of melanoma, dermatologists improved their mean biopsy sensitivity from 95.0% to 98.6% (P = .01); specificity increased from 32.1% to 56.9% (P < .001) with PLA data. CONCLUSIONS AND RELEVANCE: The noninvasive PLA enables dermatologists to significantly improve biopsy specificity while maintaining or improving sensitivity. This result may increase the number of early melanomas biopsied and reduce the number of benign lesions biopsied, thereby improving patient outcomes and reducing health care costs.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ferris LK, Jansen B, Ho J, et al. Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy. JAMA Dermatol. 2017. PMID: 28445578. doi:10.1001/jamadermatol.2017.0473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。